Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Crown Bioscience to Acquire Indivumed Service Business and Supporting Biobank
Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, has […]
Ono Pharmaceutical to Acquire Multiple Research-Stage Oncology Programs Identified with KSQ’s CRISPRomics
KSQ Therapeutics, a clinical-stage biotechnology company developing therapies to treat cancer and autoimmune diseases using […]
VITRAC Therapeutics Initiates a Phase 1 Clinical Trial for the Treatment of Non-Small Cell Lung Cancer
VITRAC Therapeutics initiated a Phase 1 Study of VIC-1911 as monotherapy and in combination with […]
Poxel Receives Orphan Drug Designation from the European Commission for PXL770 and PXL065 for Treatment of Adrenoleukodystrophy
POXEL SA, a clinical-stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic […]
Blackford and Brainomix Announce AI Partnership for Stroke Care
Blackford, the pioneering strategic imaging AI platform and solutions provider, and Brainomix, the AI-powered medtech […]
Aurinia Pharmaceuticals Announces Allowance of a New and Refined Method of Use Patent for LUPKYNIS® in the Treatment of Lupus Nephritis
Aurinia Pharmaceuticals has announced that the United States Patent and Trademark Office (USPTO) has allowed […]
STORM Therapeutics Presents STC-15 Preclinical Data Supporting Treatment of Patients with AML
STORM Therapeutics, the clinical-stage biotechnology company discovering and developing novel small molecule therapies targeting RNA […]
Sysnav Healthcare Announces a Multi-year Collaboration with Roche
Sysnav Healthcare and Roche enter a partnership to facilitate development of industry-standard outcome measurements in […]
Aculys Pharma and Four H Initiate Research Collaboration using Wearable Devices to Study Sleep Disorders in Japan
Aculys Pharma, a company focused on the development and commercialization of new innovative drugs in […]
FDA Accepts Drug Master File, Signifying a New Milestone for Touchlight's Enzymatic doggybone DNA Technology
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, today announced a […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more